SEARCH ARTICLES
LATEST ARTICLES
Table of Contents
2019 Month : July Volume : 8 Issue : 26 Page : 2043-2046URINARY N TELOPEPTIDE- THE IDEAL BIOMARKER FOR OSTEOPOROSIS.
Ganesan G. Ram1, N. Jambu2
1Associate Professor, Department of Orthopaedics, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamilnadu India.
2Professor, Department of Orthopaedics, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamilnadu India.
References :
Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International 2006;17(12):1726-33.
CrossRef | Google Scholar | PubMedCenter JR, Nguyen TV, Schneider D, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. The Lancet 1999;353(9156):878-82.
CrossRef | Google Scholar | PubMedPisani P, Renna MD, Conversano F, et al. Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques. World Journal of Radiology 2013;5(11):398-410.
CrossRef | Google Scholar | PubMedCarlson-Newberry SJ, Costello RB. Emerging technologies for nutrition research: potential for assessing military performance capability. Institute of Medicine (US) Committee on Military Nutrition Research. Washington (DC): National Academies Press (US) 1997. ISBN-10: 0-309-05797-3.
Shetty S, Kapoor N, Bondu JD, et al. Bone turnover markers: emerging tool in the management of osteoporosis. Indian Journal of Endocrinology and Metabolism 2016;20(6):846-52.
CrossRef | Google Scholar | PubMedHanson DA, Weis MA, Bollen AM, et al. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine. Journal of Bone and Mineral Research 1992;7(11):1251-8.
Google Scholar | PubMedBonde M, Qvist P, Fledelius C, et al. Immunoassay for quantifying type 1 collagen degradation products in urine evaluated. Clinical Chemistry 1994;40(11 Pt 1):2022-5.
CrossRef | Google Scholar | PubMedRabar S, Lau R, O’Flynn N, et al. Risk assessment of fragility fractures: summary of NICE guidance. BMJ 2012;345:e3698.
CrossRef | Google Scholar | PubMedKanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporosis International 2001;12(5):417-27.
CrossRef | Google Scholar | PubMedKanis JA. Diagnosis of osteoporosis and assessment of fracture risk. The Lancet 2002;359(9321):1929-36.
CrossRef | Google Scholar | PubMedGubala V, Harris LF, Ricco AJ, et al. Point of care diagnostics: status and future. Analytical Chemistry 2012;84(2):487-515.
CrossRef | Google Scholar | PubMedLiu L, Webster TJ. In situ sensor advancements for osteoporosis prevention, diagnosis and treatment. Current Osteoporosis Reports 2016;14(6):386-95.
CrossRef | Google Scholar | PubMedKuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomarker Research 2017;5(1):18.
CrossRef | Google Scholar | PubMedDelmas PD, Eastell R, Garnero P, et al. The use of biochemical markers of bone turnover in osteoporosis. Osteoporosis International 2000;11(Suppl 6):S2-S17.
Google Scholar | PubMedKleerekoper M, Edelson GW. Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects. Endocrine Practice 1996;2(1):13-9.
CrossRef | Google Scholar | PubMedLombardi G, Lanteri P, Colombini A, et al. Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling. Clinical Chemistry and Laboratory Medicine 2012;50(5):771-89.
CrossRef | Google Scholar | PubMedGreenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clinical Chemistry 2017;63(2):464-74.
CrossRef | Google Scholar | PubMedFatayerji D, Eastell R. Age‐related changes in bone turnover in men. Journal of Bone and Mineral Research 1999;14(7):1203-10.
CrossRef | Google Scholar | PubMedKhosla S, Atkinson EJ, Melton LJ 3rd, et al. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. The Journal of Clinical Endocrinology & Metabolism 1997;82(5):1522-7.
CrossRef | Google Scholar | PubMedEbeling PR, Atley LM, Guthrie JR, et al. Bone turnover markers and bone density across the menopausal transition. The Journal of Clinical Endocrinology & Metabolism 1996;81(9):3366-71.
CrossRef | Google Scholar | PubMedBell NH, Hollis BW, Shary JR, et al. Diclofenac sodium inhibits bone resorption in postmenopausal women. The American Journal of Medicine 1994;96(4):349-53.
CrossRef | Google Scholar | PubMedJones G, Nguyen T, Sambrook P, et al. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994;309(6956):691-5.
CrossRef | Google Scholar | PubMedWishart JM, Need AG, Horowitz M, et al. Effect of age on bone density and bone turnover in men. Clinical Endocrinology 1995;42(2):141-6.
CrossRef | Google Scholar | PubMed